The impact of the new technologies 
in surgery: lights an shadows 
Appropriateness and Sustainability 
Pier Paolo Dal Monte MD 
Bologna 
Italy 
1° Congress of the 
Eurasian Colorectal Technologies Association 
Guangzhou 
November 13-15. 2009
The more sophisticated the 
machine, the more barbaric the 
worker 
Karl Marx
The new technologies in surgery 
30 years that changed the world 
The “technology tree” 
New diagnostic tools 
US, 
CT, 
MRI, 
Digestive endoscopy 
New surgical instruments 
Staplers 
Endoscopes 
Haemostasis and dissecting devices 
Minimally invasive instruments 
Safety for “old procedures” 
Feasibility for “new 
procedures 
Better indications 
(precision, target) 
(NOTES): 
Efficacy 
Safety 
Less invasivity 
Better results 
Less trauma 
Shorter hospital stay/faster recovery
1) Imaging 
New technologies 
2) Suture/anastomosis: stapling devices 
3) Access: Endoscopic surgery 
minimally invasive surgery (laparoscopy) 
digestive endoscopy 
4) Haemostasis/dissection: physical (energy) 
chemical/biological (glues) 
5) Meshes/stents 
6) New devices for proctological conditions 
7) Frontiers: Robotic Surgery, NOTES, Single Access Laparoscopy
Suture/anastomosis: stapling devices 
History 
1946 
V.F. Gudov: 1° vascular stapler 
1960 
Androsov, Belkin Kalinina: Cut and suture 
staplers 
Gastric resection 
Perioperative mortality reduced from 10,4 to 3,6% 
Anastomosis time: 50% less 
Dehiscence reduced from 20-25% to 5-10% 
Gritsman J.J. :Mechanical Suture by Soviet apparatus in gastric 
resection Use in 4000 operations. Surgery 59 (5): 663-669, May 1966 
70’s 
(USSC)First single use devices
Suture/anastomosis: stapling devices 
Advantages 
• Standardisation of the technique 
• Reduction of operative time 
• Better feasibility for “difficult“ anastomoses 
(oesophago-gastric, colo-anal) 
• “Endo-staplers”: feasibility of laparoscopic colo-rectal 
surgery 
Disadvantages 
• Cost 
• Waste managment 
• Not applicable as widely as the hand 
suture
Access: Digestive endoscopy 
1868, Kussmaul performed the first esophagogastroscopy on 
a professional sword swallower, initiating efforts at 
instrumentation of the gastrointestinal tract 
1928-1932 Schindler-Wolf: semi-flexible gastroscope 
1954 H.Hopkins- N.Kapany: fiber-optic image transmission 
1957 Hirschovitz: 1° fibersope (gastroscope) 
1969 Olympus: 1° colonoscope
Access: Digestive endoscopy 
1) Accurate diagnosis 
Image enhancement 
EUS 
2) Operative treatments 
Haemostasis 
ERCP 
Excision 
Dilatation 
Palliation 
Clips 
Injective catheters 
Argon Plasma 
Laser 
Sphincteretomes 
balloons 
Advantages
Access: Laparoscopy 
1977, First Laparoscopic assisted appendicectomy was 
performed by Dekok. Appendix was exteriorized and ligated 
outside. 
1983, Semm, a German gynaecologist, performed the first 
laparoscopic appendicectomy. 
1985, The first documented laparoscopic cholecystectomy 
was performed by Erich Mühe in Germany in 1985. 
1987, Phillipe Mouret, has got the credit to perform the first 
laparoscopic cholecystectomy in Lyons, using video 
technique. Cholecystectomy is the laparoscopic procedure 
which revolutionized the general surgery
Access: Laparoscopy 
Outcomes (colorectal cancer) 
Equivalence LS-OS 
In oncological clearance and cancer-related 
mortality 
Liang Y, Li G, Chen P, Yu J. Eur J Surg Oncol. 2008 Nov;34(11):1217-24 
Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J.Cancer Treat Rev. 2008 Oct;34(6):498-504. 
Abraham NS, Byrne CM, Young JM, Solomon MJ. NZ J Surg. 2007 Jul;77(7):508-16 
Schwenk W, Haase O, Neudecker J, Müller JM.. Cochrane Database Syst Rev. 2005 Jul 20;(3)
Access: Laparoscopy 
Outcomes (colorectal cancer) 
Better outcomes for LS 
Operation time: LS > OS (30-60min) 
Blood loss: LS<OS 
Pain: LS<OS 
Bowel function: LS<OS (1-1,6 days) 
Hospital stay: LS<OS (1,6-3,5 days) 
General morbidity:LS<OS (24 vs 31%) 
Postoperative hernias): LS<OS (13vs33% at 5years) 
Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J.Cancer Treat Rev. 2008 Oct;34(6):498-504. 
Abraham NS, Byrne CM, Young JM, Solomon MJ. NZ J Surg. 2007 Jul;77(7):508-16 
Schwenk W, Haase O, Neudecker J, Müller JM.. Cochrane Database Syst Rev. 2005 Jul 20;(3) 
Laurent C, et al. Br J Surg. 2008 Jul;95(7):903-8. 
Reza MM et al. Br J Surg. 2006 Aug;93(8):921-8 
Guillou PJ, et al. Lancet. 2005 May 14-20;365(9472):1718-26
Access: Laparoscopy 
Economics (colorectal surgery) 
Comparable cost between lap and open access 
Vignali et alAnn Surg. 2005 December; 242(6): 890–896. 
Park et al.World J Surg (2007) 31:1827–1834 
Noblett et al.Surg Endosc (2007) 21: 404–408 
Dows et al.Dis Colon Rectum. 2007 Jun;50(6):908-19 
…But this is true only for the countries with high 
labour cost.
Haemostasis/dissection: 
Phisical (energy) 
•1926.First use of electrosurgical device (Harvey Cushing) 
1980’s-1990’s 
Computer controlled Bipolar electrosurgery 
Ultrasound dissection 
Argon Plasma coagulation 
Laser 
RF
Robotic surgery 
In 1985 a robot, the PUMA 560 brain 
biopsy using CT guidance. 
In 1988, the PROBOT, developed at 
Imperial College London, was used to 
perform prostatic surgery. 
Further development of robotic 
systems was carried out by Intuitive 
Surgical with the introduction of the da 
Vinci Surgical System and Computer 
Motion with the AESOP and the ZEUS 
robotic surgical system
Advantages:??? 
Robotic surgery 
Developement of a new approach with possible 
Improvements in surgical technique 
Possible applications in remote surgery 
(war surgery, space) 
Routinary use?: Expensive 
>operating time 
Organisation
Natural Orifice Transluminal Endoscopic Surgery 
(NOTES): 
Natural Orifice Transluminal Endoscopic Surgery 
(NOTES) is an emerging experimental alternative to 
conventional surgery that : 
Eliminates abdominal incisions and incision-related 
complications 
Combining endoscopic and laparoscopic techniques 
in order to access the peritoneal cavity by means of 
mouth, anus, or vagina
NOTES: Potential advantages 
Absence of incisional complications including pain, 
hernias and external wound infections. 
Novel advanced technologies and instruments must 
be developed specifically for NOTES. 
The most promising potential advantages: 
development of new instruments both for 
laparoscopy and digestive endoscopy
Assessment of the new technologies 
Undiscussed 
technique advancement 
(revolutions): Endoscopy 
Laparoscopy 
Undiscussed 
technical advancement: Staplers 
New dissection/cauterisation 
devices 
Chemical/biological Haemostasis 
Meshes/Stents 
?: 
Robotic 
Notes
The technical progress have brought many 
undoubted advantages ....... 
Safety for “old procedures” 
Feasibility for “new 
procedures 
Better indications 
(precision, target) Efficacy 
Safety 
Less invasivity 
Better results 
Less trauma 
Shorter hospital stay/faster recovery 
…but there are some shadows..
The hidden dangers of technology 
“Surgical” issues 
Different technical skills: 
Different surgical training 
Young surgeons sometimes are not 
trained enough in “old techniques” 
“Fashionable”: “New is better” 
Acritical preference of the new 
techniques
The hidden dangers of technology 
“Surgical” issues 
Tecnology “addiction”: Surgeons risk of relying too much 
on the technical tools 
Organisation problems: The new technologies require a 
more complex organisation
The hidden dangers of technology 
Ethical and economic issues 
Industry “pressures”: Conflicts of interest 
Biased studies (results, 
pathophysiology) 
Cost /benefits issues: Enthusiastic adoption of a new 
technique before scientific 
evidence 
Increase of costs for healthcare: Tranfer of money from the 
taxpayer to the industry 
Non sustainability for the 
system 
Industry driven instead of surgeon driven technological progress
The hidden dangers of technology 
Industry “pressures”: Conflicts of interest 
Biased studies 
(results, pathophysiology) 
Example: 
Is “rectal redundancy syndrome” just 
another way to name haemorrhoids ? 
(and related DRG)
The hidden dangers of technology 
Cost /benefits issues: Enthusiastic adoption of a new 
technique before scientific evidence 
Faecal incontinence 
Injectable bulking agents 
Artificial anal sphincter 
Sacral nerve stimulation 
The introduction of new technology is encouraging, both in 
the evaluation and treatment , and it is hoped will advance 
these muchneeded procedures. 
Despite this plethora of exciting advances, a stoma still 
remains the best option in patients with severe fecal 
incontinence 
Jarrett ME, et al. Br J Surg 91(12):1559-1569, 2004
The hidden dangers of technology 
Increase of costs for healthcare: Tranfer of money from the taxpayer 
to the industry 
Non sustainability for the system 
In the United States the estimate is that from 40% to 50% of 
cost increases can be traced to the technological factor, 
similar in Europe. 
The net result has been an average general system-wide cost 
increase of 10%-15% a year for the past several years, and 
with no end in sight 
D. Callahan Sustainable Medicine: Two Models of Health Care 
Giannino Bassetti Foundation - 2005
“Technological” Healthcare 
The contemporary model is based on infinite 
progress 
The constant introduction of new, and usually 
more expensive, technologies and the 
intensified use of older technologies. 
Unlimited, infinite, vision can not be paid for with 
finite funds
Sustainability-Healthcare 
Costs versus benefits (marginal returns) 
In economics, diminishing marginal returns refers to how the 
marginal contribution of a factor of production usually 
decreases as more of the factor is used. 
David Ricardo. On the Principles of Political Economy and Taxation (1817) 
Diminishing returns to increasing complexity 
J. Tainter, The collapse of complex society 1988)
Sustainability-Healthcare 
Diminishing marginal returns 
Productivity of the U.S. health care system, 1930-1982. 
Productivity index = (Life expentancy)/(National health expenditures 
as percent of GNP). 
J.Tainter, The collapse of complex society ,1988
Health indicators in industrialized countries 
Rank Country Infant 
mortality 
rate 
(X/1,000) 
Under-five 
mortality 
rate 
(X/1,000) 
3 Japan 3.2 4.2 
4 Sweden 3.2 4.0 
9 Switzerland 4.1 5.1 
11 Belgium 4.2 5.3 
12 France 4.2 5.2 
13 Spain 4.2 5.3 
14 Germany 4.3 5.4 
16 Austria 4.4 5.4 
17 Australia 4.4 5.6 
19 Netherlands 4.7 5.9 
22 United 
Kingdom 
4.8 6.0 
23 Canada 4.8 5.9 
25 Italy 5.0 6.1 
28 Cuba 5.1 6.5 
33 United States 6.3 7.8 
Rank Country 
Life expectancy 
at birth (years) 
1 Japan 82.6 79.0 86.1 
4 Switzerland 81.7 79.0 84.2 
5 Australia 81.2 78.9 83.6 
6 Spain 80.9 77.7 84.2 
7 Sweden 80.9 78.7 83.0 
10 France 80.7 77.1 84.1 
11 Canada 80.7 78.3 82.9 
12 Italy 80.5 77.5 83.5 
16 Austria 79.8 76.9 82.6 
17 Netherlands 79.8 77.5 81.9 
20 Belgium 79.4 76.5 82.3 
22 
United 
Kingdom 
79.4 77.2 81.6 
23 Germany 79.4 76.5 82.1 
37 Cuba 78.3 76.2 80.4 
38 United States 78.2 75.6 80.8 
United Nations: World Population Prospects,2006
Health expenditure versus life expectancy 
Health Expenditure 
Country % GNP Pro Capita (intl $) 
2000 2006 2000 2006 
USA 13,2 15,3 4570 6719 
Switzerland 10,3 10,8 3265 4179 
Belgium 9,1 9,9 2514 3673 
Austria 9,9 10,2 2858 3608 
Nederlands 8 9,4 2337 3481 
Germany 10,3 10,6 2670 3465 
France 10,1 11 2542 3420 
Sweden 8,2 9,2 2283 3162 
Australia 8,3 8,7 2271 3119 
UK 7,1 8,2 1846 2815 
Italy 8,1 9 2061 2631 
Japan 7,7 8,1 1967 2581 
Spain 7,2 8,4 1536 2461 
Cuba 6,7 7,7 353 674 
WHO: World Health Statistics 2009
The contemporary model 
of scientific medicine 
A. Goals 
-- unlimited scientific progress and technological 
innovation regardless of their long-term cost 
–- medical progress and technological innovation 
are allowed to set medical goals and to 
change and redefine those goals
The contemporary model 
of scientific medicine 
B. Outcomes 
Considerable medical progress and creation of 
massive medical-industrial complex 
Powerful bias toward: 
-- cure rather than care 
-- technological interventions rather than health 
promotion/disease prevention
The contemporary model 
of scientific medicine 
Result: 
Unsustainable economic pressures on all 
health care systems
Conclusions 
Technologies must be much more toughly 
evaluated 
Evaluation is generally aimed only at the 
efficacy , not at its likely economic impact. 
That impact needs to be evaluated as well
Conclusions 
Sustainability 
We do not have at present sustainable health care 
systems in any country. 
Constant medical progress, adding to costs, and 
aging populations, also adding to cost, guarantees 
they will be unsustainable 
If medicine is unaffordable, it can not be equitably 
distributed; only the wealthy will be able to get it.
A Sustainable system? 
The quiet conscience is an 
invention of the devil 
Albert Schweitzer, 
The philosophy of civilization 
What about the rest of the World?
Rank Country 
A Sustainable system? 
Life expectancy at birth 
Life expectancy at 
birth (years) 
Both Male Female 
1 Japan 82.6 79.0 86.1 
2 Hong Kong 82.2 79.4 85.1 
3 Iceland 81.8 80.2 83.3 
4 Switzerland 81.7 79.0 84.2 
5 Australia 81.2 78.9 83.6 
6 Spain 80.9 77.7 84.2 
7 Sweden 80.9 78.7 83.0 
8 Israel 80.7 78.5 82.8 
9 Macau 80.7 78.5 82.8 
10 France 80.7 77.1 84.1 
Rank Country 
Life expectancy at 
birth (years) 
Both Male Female 
185 Rwanda 46.2 44.6 47.8 
186 Liberia 45.7 44.8 46.6 
187 Congo D.R.. 44.7 43.3 46.1 
188 Afghanistan 43.8 43.9 43.8 
189 Zimbabwe 43.5 44.1 42.6 
191 Lesotho 42.6 42.9 42.3 
192 Sierra Leone 42.6 41.0 44.1 
193 Zambia 42.4 42.1 42.5 
194 Mozambique 42.1 41.7 42.4 
195 Swaziland 39.6 39.8 39.4 
United Nations: World Population Prospects,2006
A Sustainable system? 
Rank Country Infant 
Infant mortality 
mortality 
rate 
(X/1,000) 
Under-five 
mortality 
rate 
(X/1,000) 
1 Sierra Leone 160.3 278.1 
2 Afghanistan 157.0 235.4 
3 Liberia 132.5 205.2 
4 Angola 131.9 230.8 
5 Mali 128.5 199.7 
6 Chad 119.2 189.0 
7 Cote d'Ivoire 116.9 183.2 
8 Somalia 116.3 192.8 
9 Congo, D.R. 113.5 195.9 
10 Guinea- 
Bissau 
112.7 194.8 
Rank Country Infant 
World: 49.4 73.7 
mortality 
rate 
(X/1,000) 
Under-five 
mortality 
rate 
(X/1,000) 
186 Korea, South 4.1 4.8 
187 Switzerland 4.1 5.1 
188 Czech 
Republic 
3.8 4.8 
189 Finland 3.7 4.7 
190 Hong Kong 3.7 4.7 
191 Norway 3.3 4.4 
192 Sweden 3.2 4.0 
193 Japan 3.2 4.2 
194 Singapore 3.0 4.1 
195 Iceland 2.9 3.9 
United Nations: World Population Prospects,2006
Causes of death in developing and developed countries 
Causes of death in 
developing countries 
A Sustainable system? 
Number of deaths 
Causes of death in 
developed countries 
Number of deaths 
HIV-AIDS 2,678,000 
Ischaemic heart 
disease 
3,512,000 
Lower respiratory 
infections 
2,643,000 
Cerebrovascular 
disease 
3,346,000 
Ischaemic heart disease 2,484,000 
Chronic obstructive 
pulmonary disease 
1,829,000 
Diarrhoea 1,793,000 
Lower respiratory 
infections 
1,180,000 
Cerebrovascular disease 1,381,000 Lung cancer 938,000 
Childhood diseases 1,217,000 Car accident 669,000 
Malaria 1,103,000 Stomach cancer 657,000 
Tuberculosis 1,021,000 
Hypertensive heart 
disease 
635,000 
Chronic obstructive 
pulmonary disease 
748,000 Tuberculosis 571,000 
Measles 674,000 Suicide 499,000 
Who 2009
A Sustainable system? 
Tanzania: 50000:1 
Zambia: 50000:1 
Italy: 230:1 
Cuba: 170:1
Sustainability of the “World 
Healtcare system”? 
Modern technological healthcare is a 
reality only for 1/3 of the world 
population…
…a small part of the 
World is like this… 
Can we call sustainable 
a situation where…
…While a greater part 
Is like this?
Technique has arrived at such a point in 
its evolution that it is being transformed 
and is progressing almost without 
decisive intervention by man. 
Jacques Ellul 
La tecnique enju du siecle
Thank you for your 
attention 
Shadows

The impact of the new technologies in surgeryy: lights an shadows

  • 1.
    The impact ofthe new technologies in surgery: lights an shadows Appropriateness and Sustainability Pier Paolo Dal Monte MD Bologna Italy 1° Congress of the Eurasian Colorectal Technologies Association Guangzhou November 13-15. 2009
  • 2.
    The more sophisticatedthe machine, the more barbaric the worker Karl Marx
  • 3.
    The new technologiesin surgery 30 years that changed the world The “technology tree” New diagnostic tools US, CT, MRI, Digestive endoscopy New surgical instruments Staplers Endoscopes Haemostasis and dissecting devices Minimally invasive instruments Safety for “old procedures” Feasibility for “new procedures Better indications (precision, target) (NOTES): Efficacy Safety Less invasivity Better results Less trauma Shorter hospital stay/faster recovery
  • 4.
    1) Imaging Newtechnologies 2) Suture/anastomosis: stapling devices 3) Access: Endoscopic surgery minimally invasive surgery (laparoscopy) digestive endoscopy 4) Haemostasis/dissection: physical (energy) chemical/biological (glues) 5) Meshes/stents 6) New devices for proctological conditions 7) Frontiers: Robotic Surgery, NOTES, Single Access Laparoscopy
  • 5.
    Suture/anastomosis: stapling devices History 1946 V.F. Gudov: 1° vascular stapler 1960 Androsov, Belkin Kalinina: Cut and suture staplers Gastric resection Perioperative mortality reduced from 10,4 to 3,6% Anastomosis time: 50% less Dehiscence reduced from 20-25% to 5-10% Gritsman J.J. :Mechanical Suture by Soviet apparatus in gastric resection Use in 4000 operations. Surgery 59 (5): 663-669, May 1966 70’s (USSC)First single use devices
  • 6.
    Suture/anastomosis: stapling devices Advantages • Standardisation of the technique • Reduction of operative time • Better feasibility for “difficult“ anastomoses (oesophago-gastric, colo-anal) • “Endo-staplers”: feasibility of laparoscopic colo-rectal surgery Disadvantages • Cost • Waste managment • Not applicable as widely as the hand suture
  • 7.
    Access: Digestive endoscopy 1868, Kussmaul performed the first esophagogastroscopy on a professional sword swallower, initiating efforts at instrumentation of the gastrointestinal tract 1928-1932 Schindler-Wolf: semi-flexible gastroscope 1954 H.Hopkins- N.Kapany: fiber-optic image transmission 1957 Hirschovitz: 1° fibersope (gastroscope) 1969 Olympus: 1° colonoscope
  • 8.
    Access: Digestive endoscopy 1) Accurate diagnosis Image enhancement EUS 2) Operative treatments Haemostasis ERCP Excision Dilatation Palliation Clips Injective catheters Argon Plasma Laser Sphincteretomes balloons Advantages
  • 9.
    Access: Laparoscopy 1977,First Laparoscopic assisted appendicectomy was performed by Dekok. Appendix was exteriorized and ligated outside. 1983, Semm, a German gynaecologist, performed the first laparoscopic appendicectomy. 1985, The first documented laparoscopic cholecystectomy was performed by Erich Mühe in Germany in 1985. 1987, Phillipe Mouret, has got the credit to perform the first laparoscopic cholecystectomy in Lyons, using video technique. Cholecystectomy is the laparoscopic procedure which revolutionized the general surgery
  • 10.
    Access: Laparoscopy Outcomes(colorectal cancer) Equivalence LS-OS In oncological clearance and cancer-related mortality Liang Y, Li G, Chen P, Yu J. Eur J Surg Oncol. 2008 Nov;34(11):1217-24 Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J.Cancer Treat Rev. 2008 Oct;34(6):498-504. Abraham NS, Byrne CM, Young JM, Solomon MJ. NZ J Surg. 2007 Jul;77(7):508-16 Schwenk W, Haase O, Neudecker J, Müller JM.. Cochrane Database Syst Rev. 2005 Jul 20;(3)
  • 11.
    Access: Laparoscopy Outcomes(colorectal cancer) Better outcomes for LS Operation time: LS > OS (30-60min) Blood loss: LS<OS Pain: LS<OS Bowel function: LS<OS (1-1,6 days) Hospital stay: LS<OS (1,6-3,5 days) General morbidity:LS<OS (24 vs 31%) Postoperative hernias): LS<OS (13vs33% at 5years) Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J.Cancer Treat Rev. 2008 Oct;34(6):498-504. Abraham NS, Byrne CM, Young JM, Solomon MJ. NZ J Surg. 2007 Jul;77(7):508-16 Schwenk W, Haase O, Neudecker J, Müller JM.. Cochrane Database Syst Rev. 2005 Jul 20;(3) Laurent C, et al. Br J Surg. 2008 Jul;95(7):903-8. Reza MM et al. Br J Surg. 2006 Aug;93(8):921-8 Guillou PJ, et al. Lancet. 2005 May 14-20;365(9472):1718-26
  • 12.
    Access: Laparoscopy Economics(colorectal surgery) Comparable cost between lap and open access Vignali et alAnn Surg. 2005 December; 242(6): 890–896. Park et al.World J Surg (2007) 31:1827–1834 Noblett et al.Surg Endosc (2007) 21: 404–408 Dows et al.Dis Colon Rectum. 2007 Jun;50(6):908-19 …But this is true only for the countries with high labour cost.
  • 13.
    Haemostasis/dissection: Phisical (energy) •1926.First use of electrosurgical device (Harvey Cushing) 1980’s-1990’s Computer controlled Bipolar electrosurgery Ultrasound dissection Argon Plasma coagulation Laser RF
  • 14.
    Robotic surgery In1985 a robot, the PUMA 560 brain biopsy using CT guidance. In 1988, the PROBOT, developed at Imperial College London, was used to perform prostatic surgery. Further development of robotic systems was carried out by Intuitive Surgical with the introduction of the da Vinci Surgical System and Computer Motion with the AESOP and the ZEUS robotic surgical system
  • 15.
    Advantages:??? Robotic surgery Developement of a new approach with possible Improvements in surgical technique Possible applications in remote surgery (war surgery, space) Routinary use?: Expensive >operating time Organisation
  • 16.
    Natural Orifice TransluminalEndoscopic Surgery (NOTES): Natural Orifice Transluminal Endoscopic Surgery (NOTES) is an emerging experimental alternative to conventional surgery that : Eliminates abdominal incisions and incision-related complications Combining endoscopic and laparoscopic techniques in order to access the peritoneal cavity by means of mouth, anus, or vagina
  • 17.
    NOTES: Potential advantages Absence of incisional complications including pain, hernias and external wound infections. Novel advanced technologies and instruments must be developed specifically for NOTES. The most promising potential advantages: development of new instruments both for laparoscopy and digestive endoscopy
  • 18.
    Assessment of thenew technologies Undiscussed technique advancement (revolutions): Endoscopy Laparoscopy Undiscussed technical advancement: Staplers New dissection/cauterisation devices Chemical/biological Haemostasis Meshes/Stents ?: Robotic Notes
  • 19.
    The technical progresshave brought many undoubted advantages ....... Safety for “old procedures” Feasibility for “new procedures Better indications (precision, target) Efficacy Safety Less invasivity Better results Less trauma Shorter hospital stay/faster recovery …but there are some shadows..
  • 20.
    The hidden dangersof technology “Surgical” issues Different technical skills: Different surgical training Young surgeons sometimes are not trained enough in “old techniques” “Fashionable”: “New is better” Acritical preference of the new techniques
  • 21.
    The hidden dangersof technology “Surgical” issues Tecnology “addiction”: Surgeons risk of relying too much on the technical tools Organisation problems: The new technologies require a more complex organisation
  • 22.
    The hidden dangersof technology Ethical and economic issues Industry “pressures”: Conflicts of interest Biased studies (results, pathophysiology) Cost /benefits issues: Enthusiastic adoption of a new technique before scientific evidence Increase of costs for healthcare: Tranfer of money from the taxpayer to the industry Non sustainability for the system Industry driven instead of surgeon driven technological progress
  • 23.
    The hidden dangersof technology Industry “pressures”: Conflicts of interest Biased studies (results, pathophysiology) Example: Is “rectal redundancy syndrome” just another way to name haemorrhoids ? (and related DRG)
  • 24.
    The hidden dangersof technology Cost /benefits issues: Enthusiastic adoption of a new technique before scientific evidence Faecal incontinence Injectable bulking agents Artificial anal sphincter Sacral nerve stimulation The introduction of new technology is encouraging, both in the evaluation and treatment , and it is hoped will advance these muchneeded procedures. Despite this plethora of exciting advances, a stoma still remains the best option in patients with severe fecal incontinence Jarrett ME, et al. Br J Surg 91(12):1559-1569, 2004
  • 25.
    The hidden dangersof technology Increase of costs for healthcare: Tranfer of money from the taxpayer to the industry Non sustainability for the system In the United States the estimate is that from 40% to 50% of cost increases can be traced to the technological factor, similar in Europe. The net result has been an average general system-wide cost increase of 10%-15% a year for the past several years, and with no end in sight D. Callahan Sustainable Medicine: Two Models of Health Care Giannino Bassetti Foundation - 2005
  • 26.
    “Technological” Healthcare Thecontemporary model is based on infinite progress The constant introduction of new, and usually more expensive, technologies and the intensified use of older technologies. Unlimited, infinite, vision can not be paid for with finite funds
  • 27.
    Sustainability-Healthcare Costs versusbenefits (marginal returns) In economics, diminishing marginal returns refers to how the marginal contribution of a factor of production usually decreases as more of the factor is used. David Ricardo. On the Principles of Political Economy and Taxation (1817) Diminishing returns to increasing complexity J. Tainter, The collapse of complex society 1988)
  • 28.
    Sustainability-Healthcare Diminishing marginalreturns Productivity of the U.S. health care system, 1930-1982. Productivity index = (Life expentancy)/(National health expenditures as percent of GNP). J.Tainter, The collapse of complex society ,1988
  • 29.
    Health indicators inindustrialized countries Rank Country Infant mortality rate (X/1,000) Under-five mortality rate (X/1,000) 3 Japan 3.2 4.2 4 Sweden 3.2 4.0 9 Switzerland 4.1 5.1 11 Belgium 4.2 5.3 12 France 4.2 5.2 13 Spain 4.2 5.3 14 Germany 4.3 5.4 16 Austria 4.4 5.4 17 Australia 4.4 5.6 19 Netherlands 4.7 5.9 22 United Kingdom 4.8 6.0 23 Canada 4.8 5.9 25 Italy 5.0 6.1 28 Cuba 5.1 6.5 33 United States 6.3 7.8 Rank Country Life expectancy at birth (years) 1 Japan 82.6 79.0 86.1 4 Switzerland 81.7 79.0 84.2 5 Australia 81.2 78.9 83.6 6 Spain 80.9 77.7 84.2 7 Sweden 80.9 78.7 83.0 10 France 80.7 77.1 84.1 11 Canada 80.7 78.3 82.9 12 Italy 80.5 77.5 83.5 16 Austria 79.8 76.9 82.6 17 Netherlands 79.8 77.5 81.9 20 Belgium 79.4 76.5 82.3 22 United Kingdom 79.4 77.2 81.6 23 Germany 79.4 76.5 82.1 37 Cuba 78.3 76.2 80.4 38 United States 78.2 75.6 80.8 United Nations: World Population Prospects,2006
  • 30.
    Health expenditure versuslife expectancy Health Expenditure Country % GNP Pro Capita (intl $) 2000 2006 2000 2006 USA 13,2 15,3 4570 6719 Switzerland 10,3 10,8 3265 4179 Belgium 9,1 9,9 2514 3673 Austria 9,9 10,2 2858 3608 Nederlands 8 9,4 2337 3481 Germany 10,3 10,6 2670 3465 France 10,1 11 2542 3420 Sweden 8,2 9,2 2283 3162 Australia 8,3 8,7 2271 3119 UK 7,1 8,2 1846 2815 Italy 8,1 9 2061 2631 Japan 7,7 8,1 1967 2581 Spain 7,2 8,4 1536 2461 Cuba 6,7 7,7 353 674 WHO: World Health Statistics 2009
  • 31.
    The contemporary model of scientific medicine A. Goals -- unlimited scientific progress and technological innovation regardless of their long-term cost –- medical progress and technological innovation are allowed to set medical goals and to change and redefine those goals
  • 32.
    The contemporary model of scientific medicine B. Outcomes Considerable medical progress and creation of massive medical-industrial complex Powerful bias toward: -- cure rather than care -- technological interventions rather than health promotion/disease prevention
  • 33.
    The contemporary model of scientific medicine Result: Unsustainable economic pressures on all health care systems
  • 34.
    Conclusions Technologies mustbe much more toughly evaluated Evaluation is generally aimed only at the efficacy , not at its likely economic impact. That impact needs to be evaluated as well
  • 35.
    Conclusions Sustainability Wedo not have at present sustainable health care systems in any country. Constant medical progress, adding to costs, and aging populations, also adding to cost, guarantees they will be unsustainable If medicine is unaffordable, it can not be equitably distributed; only the wealthy will be able to get it.
  • 36.
    A Sustainable system? The quiet conscience is an invention of the devil Albert Schweitzer, The philosophy of civilization What about the rest of the World?
  • 37.
    Rank Country ASustainable system? Life expectancy at birth Life expectancy at birth (years) Both Male Female 1 Japan 82.6 79.0 86.1 2 Hong Kong 82.2 79.4 85.1 3 Iceland 81.8 80.2 83.3 4 Switzerland 81.7 79.0 84.2 5 Australia 81.2 78.9 83.6 6 Spain 80.9 77.7 84.2 7 Sweden 80.9 78.7 83.0 8 Israel 80.7 78.5 82.8 9 Macau 80.7 78.5 82.8 10 France 80.7 77.1 84.1 Rank Country Life expectancy at birth (years) Both Male Female 185 Rwanda 46.2 44.6 47.8 186 Liberia 45.7 44.8 46.6 187 Congo D.R.. 44.7 43.3 46.1 188 Afghanistan 43.8 43.9 43.8 189 Zimbabwe 43.5 44.1 42.6 191 Lesotho 42.6 42.9 42.3 192 Sierra Leone 42.6 41.0 44.1 193 Zambia 42.4 42.1 42.5 194 Mozambique 42.1 41.7 42.4 195 Swaziland 39.6 39.8 39.4 United Nations: World Population Prospects,2006
  • 38.
    A Sustainable system? Rank Country Infant Infant mortality mortality rate (X/1,000) Under-five mortality rate (X/1,000) 1 Sierra Leone 160.3 278.1 2 Afghanistan 157.0 235.4 3 Liberia 132.5 205.2 4 Angola 131.9 230.8 5 Mali 128.5 199.7 6 Chad 119.2 189.0 7 Cote d'Ivoire 116.9 183.2 8 Somalia 116.3 192.8 9 Congo, D.R. 113.5 195.9 10 Guinea- Bissau 112.7 194.8 Rank Country Infant World: 49.4 73.7 mortality rate (X/1,000) Under-five mortality rate (X/1,000) 186 Korea, South 4.1 4.8 187 Switzerland 4.1 5.1 188 Czech Republic 3.8 4.8 189 Finland 3.7 4.7 190 Hong Kong 3.7 4.7 191 Norway 3.3 4.4 192 Sweden 3.2 4.0 193 Japan 3.2 4.2 194 Singapore 3.0 4.1 195 Iceland 2.9 3.9 United Nations: World Population Prospects,2006
  • 39.
    Causes of deathin developing and developed countries Causes of death in developing countries A Sustainable system? Number of deaths Causes of death in developed countries Number of deaths HIV-AIDS 2,678,000 Ischaemic heart disease 3,512,000 Lower respiratory infections 2,643,000 Cerebrovascular disease 3,346,000 Ischaemic heart disease 2,484,000 Chronic obstructive pulmonary disease 1,829,000 Diarrhoea 1,793,000 Lower respiratory infections 1,180,000 Cerebrovascular disease 1,381,000 Lung cancer 938,000 Childhood diseases 1,217,000 Car accident 669,000 Malaria 1,103,000 Stomach cancer 657,000 Tuberculosis 1,021,000 Hypertensive heart disease 635,000 Chronic obstructive pulmonary disease 748,000 Tuberculosis 571,000 Measles 674,000 Suicide 499,000 Who 2009
  • 40.
    A Sustainable system? Tanzania: 50000:1 Zambia: 50000:1 Italy: 230:1 Cuba: 170:1
  • 41.
    Sustainability of the“World Healtcare system”? Modern technological healthcare is a reality only for 1/3 of the world population…
  • 42.
    …a small partof the World is like this… Can we call sustainable a situation where…
  • 43.
    …While a greaterpart Is like this?
  • 44.
    Technique has arrivedat such a point in its evolution that it is being transformed and is progressing almost without decisive intervention by man. Jacques Ellul La tecnique enju du siecle
  • 45.
    Thank you foryour attention Shadows